本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BioLine Rx

2.85
-0.1500-5.00%
盤後2.80-0.0500-1.75%17:03 EDT
成交量:7,043
成交額:2.00萬
市值:1,240.14萬
市盈率:-1.55
高:3.03
開:3.03
低:2.66
收:3.00
52周最高:4.56
52周最低:2.15
股本:435.14萬
流通股本:417.35萬
量比:1.01
換手率:0.17%
股息:- -
股息率:- -
每股收益(TTM):-1.8408
每股收益(LYR):-0.2856
淨資產收益率:-46.72%
總資產收益率:-16.55%
市淨率:0.74
市盈率(LYR):-9.98

資料載入中...

2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/30

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/07/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/05

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/05/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]